ARCHIVES

Cancer center directors to develop blueprint for progress that’s “honest,” M.D. Anderson’s John Mendelsohn says.

This article is from The Cancer Letter archive.

Vol. 31 No. 43 | November 23, 2005

Download PDF Visit The Full Archive

Related Articles

Self-Collected Pap Smear Tests Could Advance HPV Screening

January 27, 2012

Heart Failure Rare Among Leukemia Patients On Imatinib

September 28, 2007

Organ Systems Program to Submit 10 More Concepts In Fall

July 10, 1987

NCAB Settles New Touchy PDQ Issues

June 7, 1985

Cancer Congress Scientific Program To Update Basic, Clinical Science

April 2, 1982

FDA News: FDA Approved A Supplemental New Drug Application For Nexavar Tablets (Sorafenib) For The Treatment Of Patients With Locally Recurrent Or Metastatic, Progressive, Differentiated Thyroid Carcinoma Refractory To Radioactive Iodine Treatment.

December 17, 2013